Abstract
In Pharmaceutical Care, pharmacists collect and evaluate information about the patient, including the identification of possible Drug-Related Problems (DRPs), in addition to encouraging self-care and promoting better pharmacotherapy. The objective was to evaluate the impact of pharmaceutical care on the quality of life of a patient with breast cancer and metabolic syndrome. Pharmacotherapeutic follow-up was carried out for one semester. In the meantime, adherence (BaMQ), degree of depression (PHQ-9) and quality of life (SF-36) of the patient were evaluated before, during and after the interventions. Patient undergoing chemotherapy for breast cancer, undergoing treatment for diabetes, hypertension, dyslipidemia, in addition to practicing self-medication. Before follow-up, he presented drastic fluctuations in blood glucose and blood pressure, poor eating habits, dyslipidemia, sedentary lifestyle and complaints of pain. After the interventions, he showed a relative improvement in the metabolic syndrome linked to better life habits, despite the aggressive treatment of chemotherapy. The interventions carried out during the pharmaceutical follow-up had positive impacts, which reinforces the importance of the pharmacist in satisfactory primary care and health promotion.
DOI:https://doi.org/10.56238/innovhealthknow-045